Actos Franchise Drives Takeda's Pharmaceutical Sales Growth
This article was originally published in The Pink Sheet Daily
Executive SummaryFirm continues FDA discussions for new cholesterol candidate Tak-475.
You may also be interested in...
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.